Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT01238822 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Methylphenidate
DRUG: placebo
DRUG: Methylphenidate
DRUG: Methylphenidate

Sponsor

Children's Hospital Medical Center, Cincinnati